Europace 2006; 8 :651–745; doi:10.1093/europace/eul097

The following corrections are needed to Table 23, page 702:

  1. This table should be retitled to “Pharmacological treatment before cardioversion in patients with persistent AF: Effects of various antiarrhythmic drugs on immediate recurrence, outcome of transthoracic direct-current shock, or both”

  2. Quinidine should be deleted from the table (Enhance conversion by DC shock and prevent IRAF a column).

  3. The authors prefer that the third column be transposed to the fifth column.

  4. The recommendation class for the treatments with known efficacy (row 1, column 3) is IIa rather than I.

These errors have been corrected in the current online version of the article.